Pharmaceutical Preparations
Standard Industrial Classification: SIC 2834
Industry Insider Sentiment Analysis
The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-13 04:34 | 2025-03-10 | IRON | Disc Medicine, Inc. | ORBIMED ADVISORS LLC | Director | SELL | $54.31 | 312,384 | $16,965,606 | 194,209 |
| 2025-03-13 00:02 | 2025-03-10 | BGNE | BeOne Medicines Ltd. | OYLER JOHN | Director, Officer | OPT+S | $242.67 | 41,210 | $10,000,484 | 0 |
| 2025-03-12 02:53 | 2025-03-11 | DERM | Journey Medical Corp | Maraoui Claude | Director, Officer | SELL | $5.01 | 49,271 | $246,848 | 2,003,147 |
| 2025-03-11 23:33 | 2025-03-07 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | Director, Officer | OPT+S | $30.02 | 200 | $6,004 | 14,863 |
| 2025-03-12 01:42 | 2025-03-11 | ABCL | AbCellera Biologics Inc. | Thermopylae Holdings Ltd. | 10% owner | BUY | $2.16 | 343,631 | $742,243 | 56,143,640 |
| 2025-03-12 00:18 | 2025-03-07 | ELVN | Enliven Therapeutics, Inc. | Patel Anish | Officer | SELL | $21.44 | 6,667 | $142,936 | 323,310 |
| 2025-03-11 23:20 | 2025-03-10 | ZTS | Zoetis Inc. | Lagano Roxanne | Officer | SELL | $170.00 | 326 | $55,420 | 15,781 |
| 2025-03-11 23:20 | 2025-03-11 | ZTS | Zoetis Inc. | Reed Willie M | Director | SELL | $166.14 | 1,210 | $201,029 | 11,245 |
| 2025-03-11 13:10 | 2025-03-10 | ETST | Earth Science Tech, Inc. | Tabraue Mario Guillermo | Director, Officer | BUY | $0.14 | 40,000 | $5,600 | 12,422,023 |
| 2025-03-12 00:13 | 2025-03-07 | ELAN | Elanco Animal Health Inc | Kurzius Lawrence Erik | Director | BUY | $10.55 | 20,000 | $211,000 | 111,459 |
| 2025-03-11 23:28 | 2025-03-10 | XNCR | Xencor Inc | Valente Nancy | Officer | SELL | $13.60 | 2,565 | $34,877 | 53,785 |
| 2025-03-11 23:26 | 2025-03-10 | XNCR | Xencor Inc | Eckert Celia | Officer | SELL | $13.60 | 5,740 | $78,047 | 63,507 |
| 2025-03-11 23:25 | 2025-03-10 | XNCR | Xencor Inc | Desjarlais John R | Officer | SELL | $13.60 | 9,697 | $131,851 | 236,574 |
| 2025-03-11 23:23 | 2025-03-10 | XNCR | Xencor Inc | Dahiyat Bassil I | Director, Officer | SELL | $13.60 | 19,716 | $268,080 | 465,419 |
| 2025-03-12 01:17 | 2025-03-10 | JAZZ | Jazz Pharmaceuticals plc | Carr Patricia | Officer | SELL | $137.81 | 1,140 | $157,103 | 7,012 |
| 2025-03-11 23:32 | 2025-03-07 | EWTX | Edgewise Therapeutics, Inc. | KOCH KEVIN | Director, Officer | OPT+S | $30.00 | 100 | $3,000 | 14,478 |
| 2025-03-12 02:01 | 2025-03-10 | CYRX | Cryoport, Inc. | Sawicki Mark W | Officer | OPT+S | $4.88 | 1,583 | $7,724 | 78,528 |
| 2025-03-12 02:01 | 2025-03-10 | CYRX | Cryoport, Inc. | SHELTON JERRELL | Director, Officer | OPT+S | $4.88 | 4,173 | $20,360 | 740,019 |
| 2025-03-12 02:00 | 2025-03-10 | CYRX | Cryoport, Inc. | STEFANOVICH ROBERT | Officer | OPT+S | $4.88 | 1,256 | $6,128 | 183,078 |
| 2025-03-11 23:01 | 2025-03-07 | GYRE | GYRE THERAPEUTICS, INC. | Ma Songjiang | Director, Officer | SELL | $10.19 | 4,000 | $40,776 | 2,839,260 |
| 2025-03-11 23:30 | 2025-03-10 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Officer | OPT+S | $320.09 | 2,000 | $640,184 | 0 |
| 2025-03-11 01:21 | 2025-03-06 | DERM | Journey Medical Corp | Maraoui Claude | Director, Officer | SELL | $5.03 | 40,456 | $203,449 | 2,052,418 |
| 2025-03-10 23:48 | 2025-03-06 | NUVL | Nuvalent, Inc. | Noci Darlene | Officer | OPT+S | $71.87 | 34,000 | $2,443,577 | 48,034 |
| 2025-03-10 23:18 | 2025-03-07 | SEPN | Septerna, Inc. | Ezekowitz Alan | Director | BUY | $6.93 | 13,319 | $92,270 | 117,420 |
| 2025-03-10 23:43 | 2025-03-06 | BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Director | OPT+S | $32.58 | 12,875 | $419,500 | 1,764 |
| 2025-03-10 23:10 | 2024-09-27 | BIOA | BioAge Labs, Inc. | Barton Shane | Officer | BUY | $18.00 | 2,632 | $47,376 | 2,632 |
| 2025-03-10 23:11 | 2024-09-27 | BIOA | BioAge Labs, Inc. | Hemrajani Rekha | Director | BUY | $18.00 | 3,000 | $54,000 | 3,000 |
| 2025-03-11 00:11 | 2025-03-10 | ABCL | AbCellera Biologics Inc. | Montalbano John S. | Director | BUY | $2.30 | 25,000 | $57,500 | 171,000 |
| 2025-03-11 03:07 | 2025-03-10 | PRGO | PERRIGO Co plc | Janish Ronald Craig | Officer | OPT+S | $27.44 | 7,800 | $214,032 | 33,666 |
| 2025-03-10 19:53 | 2025-03-06 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | Officer | SELL | $40.40 | 1,785 | $72,114 | 106,169 |
| 2025-03-11 00:12 | 2025-03-06 | MIRM | Mirum Pharmaceuticals, Inc. | Heron Patrick J | Director | BUY | $43.69 | 1,915 | $83,661 | 165,825 |
| 2025-03-11 01:43 | 2025-03-07 | KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | Director, Officer | OPT+S | $11.97 | 6,669 | $79,828 | 287,811 |
| 2025-03-10 23:02 | 2025-03-06 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Tupper Colleen | Officer | SELL | $30.00 | 3,453 | $103,591 | 175,691 |
| 2025-03-10 23:01 | 2025-03-06 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | Officer | SELL | $30.00 | 5,643 | $169,300 | 142,063 |
| 2025-03-11 04:44 | 2025-03-07 | DVAX | Dynavax Technologies Corporation | Novack David F | Officer | SELL | $14.39 | 32,764 | $471,474 | 22,098 |
| 2025-03-11 03:28 | 2025-03-07 | ANIP | Ani Pharmaceuticals Inc. | Davis Krista | Officer | SELL | $60.86 | 1,000 | $60,860 | 66,525 |
| 2025-03-08 00:04 | 2025-03-05 | DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Officer | SELL | $11.83 | 1,094 | $12,942 | 197,993 |
| 2025-03-08 00:08 | 2025-03-05 | DYN | Dyne Therapeutics, Inc. | Kerr Douglas | Officer | SELL | $11.83 | 1,343 | $15,888 | 94,157 |
| 2025-03-08 00:06 | 2025-03-05 | DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | Officer | SELL | $11.83 | 917 | $10,848 | 123,673 |
| 2025-03-08 01:30 | 2025-03-05 | AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Officer | OPT+S | $44.53 | 12,500 | $556,590 | 170,237 |
| 2025-03-08 00:05 | 2025-03-05 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Daniell Richard | Officer | OPT+S | $15.91 | 70,961 | $1,128,642 | 48,384 |
| 2025-03-08 00:17 | 2025-03-05 | AMRX | Amneal Pharmaceuticals Inc. | Daly Jason B. | Officer | SELL | $8.80 | 90,000 | $792,162 | 32,606 |
| 2025-03-08 00:16 | 2025-03-05 | AMRX | Amneal Pharmaceuticals Inc. | Alva Emily Peterson | Director | SELL | $8.90 | 80,000 | $712,000 | 170,771 |
| 2025-03-07 23:32 | 2025-03-06 | ABCL | AbCellera Biologics Inc. | Montalbano John S. | Director | BUY | $2.34 | 60,000 | $140,568 | 146,000 |
| 2025-03-08 03:24 | 2025-03-05 | BGNE | BeOne Medicines Ltd. | Wu Xiaobin | Officer | OPT+S | $261.59 | 51,921 | $13,581,905 | 0 |
| 2025-03-08 05:05 | 2025-03-07 | WVE | Wave Life Sciences Ltd. | BOLNO PAUL | Director, Officer | OPT+S | $9.57 | 169,025 | $1,617,569 | 338,351 |
| 2025-03-08 01:25 | 2025-03-07 | AUPH | Aurinia Pharmaceuticals Inc. | Keenan Greg | Officer | SELL | $8.23 | 8,305 | $68,350 | 153,484 |
| 2025-03-08 00:30 | 2025-03-06 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Smethurst Dominic | Officer | SELL | $6.78 | 6,393 | $43,330 | 70,807 |
| 2025-03-08 01:12 | 2025-03-05 | SPRY | ARS Pharmaceuticals, Inc. | Shawver Laura | Director | OPT+S | $11.21 | 50,000 | $560,445 | 210,346 |
| 2025-03-07 14:02 | 2025-03-04 | ETST | Earth Science Tech, Inc. | Rose Christopher Alan | Officer | BUY | $0.16 | 31,500 | $4,936 | 85,151 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Pharmaceutical Preparations
Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.